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Abstract 
Rationale: A rapid and early loss of skeletal muscle mass underlies the physical disability 
common amongst survivors of critical illness. However, skeletal muscle function depends 
not only on its quantity but its quality, which may be adversely affected.  
Objectives: To characterise the changes in macroscopic muscle echogenicity and fascial 
characteristics that occur early in critical illness, and to relate these to microscopic 
histologically-defined myofibre necrosis and fascial pathology.  
Methods and Measurements: Thirty subjects comprised a subgroup of patients recruited to 
the Musculoskeletal Ultrasound in Critical Illness: Longitudinal Evaluation (MUSCLE) study. 
Comparisons were made between sequential Vastus Lateralis histological specimens and 
ultrasound assessment of Rectus Femoris echogenicity.  
Main Results: Change in muscle echogenicity was greater in patients who developed muscle 
necrosis (n=15) than in those who did not (8.2%, (95%CI -5.3- 21.7), versus -15.0%, (95%CI -
28.9- -1.09), p=0.016).  The AUROC for ultrasound echogenicity’s prediction of myofibre 
necrosis was 0.74 (95%CI 0.565-0.919, p=0.024) increasing to 0.85 (95%CI 0.703 -0.995, 
p=0.003) with the removal of those with potential iatrogenic muscle damage.  Fasciitis was 
observed in 18 out of 30 biopsies (60%).  
Conclusions: Myofibre necrosis and fascial inflammation can be detected noninvasively 
using ultrasound in the critically ill. Fasciitis precedes and frequently accompanies muscle 
necrosis. These findings may have functional implications for survivors of critical illness. 
 
  
Background 
Acute loss of skeletal muscle mass, greatest in patients with multi-organ failure, contributes 
to the ongoing physical disability common amongst survivors of critical illness (1, 2). 
However, skeletal muscle functional capacity depends not only on its quantity but its 
quality- recent data suggest that this, too, may be adversely affected in critical illness. It has 
been previously demonstrated that i) protein content (relative to that of Deoxyribonucleic 
Acid) decreases disproportionately more than radiologically-assessed muscle mass (2), ii) 
myofibre necrosis occurs in up to 40% of patients (2), and  iii) the myosin/actin (contractile 
protein) ratio falls (3). Nonetheless, qualitative changes remain poorly explored and 
described, particularly at the whole muscle level.  
 Muscle ultrasound is increasingly used for assessment of muscle mass (4-6). Whole muscle 
and myofibre cross-sectional area changes are comparable in the critical care setting (2). 
Muscle ultrasound echogenicity (the differential acoustic impedance of tissue) (7) is 
normally low: healthy tissue contains little fibrous tissue, leading to little sound reflection 
(8). In disease, replacement of muscle with fat or fibrous tissue increases echogenicity (9). 
Increased echogenicity can discriminate between myopathies, neurogenic disorders and 
non-neuromuscular diseases in children (10, 11), and correlates with reduced strength and 
function with age (12-15).   
Muscle echogenicity also increases in critical illness (16, 17) although its aetiology or 
associated histopathological characteristics remain unknown.  Ultrasound can also identify 
fluid accumulation in fascial planes, to which inflammation and infection may substantially 
contribute (18, 19).  Fluid shifts are commonly seen in critical illness, and whilst fascial 
pathology has not been described in the critically ill, ultrasound-detectable fasciitis is a well-
described phenomenon in other disease states (20). 
We thus sought to use B-mode ultrasound to characterise the changes in muscle 
echogenicity  and fascial characteristics that occur early in critical illness, and to relate these 
to the presence of histologically defined myofibre necrosis and fascial histopathology.  
Methods 
Subjects comprised a subgroup of those patients recruited to the Musculoskeletal 
Ultrasound in Critical Illness: Longitudinal Evaluation (MUSCLE) study (NCT01106300, 
www.clinicaltrials.gov) (2). In brief, appropriate ethics committee approval was obtained. 
Patients were recruited within 24 hours of admission to a university hospital and a 
community hospital (August 2009-April 2011). All were anticipated to (a) be invasively 
ventilated for >48 hours, (b) spend > 7 days in the intensive care unit (ICU) and (c) survive 
ICU. Patients were subsequently excluded if these criteria were not met.  Patients were also 
excluded if pregnant, a lower limb amputee, or had a primary neuromuscular pathology or 
disseminated cancer.  At enrolment, assent was obtained from the next-of-kin with 
retrospective patient consent obtained later. 
 
Histological determination of myofibre necrosis, fascial pathology and muscle fibre type  
Sequential Vastus Lateralis muscle biopsies acquired via the conchotome technique (21) 
(performed on days 1, 3, 7 and 10 of ICU admission) were examined for the development of 
muscle fibre necrosis (as previously reported (2)). Pre-existing muscle pathology was 
determined by screening for the presence of fibre atrophy (angular or polygonal fibres of 
<30μm diameter). Myopathic changes during admission were defined by the presence of 
one or more of the following: excessive fibre size variation and/or internal nucleation, 
whorled and split fibres, fibro-fatty infiltration, necrosis and regeneration, and any deviation 
in the fibre-typing expected at the biopsy site (checkerboard distribution of roughly one-
third of type I, and two-thirds of type II fibres).  
Quantification of type I and type II fibre numbers was performed on sections stained using 
Adenosine Tri-phosphatase enzyme (ATPase) histochemistry at pH 10.1 and anti-fast myosin 
heavy chain antibodies (Clone MY-32, www.sigmaaldrich.com).  
Necrotic fibres were identified in Haematoxylin and Eosin (HE-) -stained sections as fibres 
with loss of cytoplasmic eosinophilia and basophilic nuclear staining, lytic changes and 
macrophage infiltration. Severity was assessed semi-quantitatively on a range from mild 
(single necrotic fibres) to severe (large groups or confluent anatomical zones of necrosis). 
Regenerating fibres were identified by their increased cytoplasmic basophilia, large vesicular 
nuclei and prominent nucleoli. Muscle fascia (deep fascia/epimysium, perimysial septa and 
endomysial connective tissue) was assessed for presence of oedema (interstitial fluid 
causing tissue pallor and separation between fascicles and individual fibres), fragmentation 
and cellular infiltrates (neutrophil polymorphs, macrophages and lymphocytes). Sharply 
circumscribed groups of necrotic/regenerating fibres might have resulted from a previous 
biopsy, and affected samples were thus excluded from the analysis. 
Muscle and fascial echogenicity  
Ultrasound-assessment of Rectus Femoris (RF) anatomical cross sectional area (RFCSA) in 
critical illness has been previously reported(2), as have methods of acquisition and data 
reliability (2, 22, 23). An excess of gel was placed on the skin to prevent pressure distortion, 
judged by maintenance of the convex shape of both the dermal layer and the superior RF 
border. These images were grey-scaled and RF echogenicity (RFECHO) determined by 
histogram analysis of pixel intensity (pixel distribution having been removed by grey-scaling 
images) of the pre-demarcated RFCSA (Adobe Photoshop Elements 12, www.adobe.com). 
Images without standardized gain settings were not analyzed. The depth setting was chosen 
to visualize the femur on day 1, and the same setting was used on subsequent images. 
Three images were analysed for day 1 and day 10 timepoints, and the mean pixel intensity 
calculated. Fascial tissue echogenicity (FASECHO) was determined from the same grey-scaled 
images using a standardised selection window applied to fascia overlying RF. Inter-image 
repeatability was assessed for all 30 subjects for two images taken on day 1, and the results 
available in the online supplement. 
Statistical analysis 
Data were collected prospectively. Data were assessed for normality using D’Agostino and 
Pearson omnibus normality tests, and analysed using paired two-tailed Student’s t-test or 
Mann Whitney U test as appropriate. Normally-distributed data were described using mean 
(95% Confidence Interval) and non-normally distributed data as median (range). Categorical 
variables were analysed by χ2 testing.  Multivariable and univariable linear regression 
analyses were applied (Statistical Package for the Social Sciences version 17 (SPSS, Inc, 
Chicago, Ill). Area Under Receiver Operator Curves (AUROC) was calculated for the ability of 
muscle ultrasound to predict our predefined primary endpoints of muscle necrosis and soft 
tissue infiltrate. Statistical significance was defined at the 95% level. 
 
Results 
Of the initial cohort of 37 patients with serial muscle biopsies and ultrasound, 30 patients 
had images acquired with standardised image settings. Characteristics of these patients are 
shown in Table 1. 
 
Histological assessment of skeletal muscle biopsies 
The proportion of Type I to Type II fibres did not change from day 1 to day 10 in either the 
cohort as a whole, nor differentially in those with or without chronic disease prior to critical 
illness (Table 2).  Type I fibres lost 4.6% (95%CI -7.4—2.1) per day and Type II fibres 3.7% 
(95%CI -6.6—0.8) of cross sectional area per day, which was not significantly different 
(p=0.629). 
 
Myonecrosis  
As previously reported, myofibre necrosis was observed from day 7 in 15 of the 30 patients 
(2). Of these, four individual samples from different patients demonstrated sharply 
circumscribed necrotic areas, and were thus excluded from analysis (above). As previously 
reported, macrophages dominated the accompanying cellular inflammatory infiltrates(2). 
Our new analysis reveals that these macrophages are not merely infiltrating necrotic fibres, 
but also accumulate in the interfascicular septa and fascicular interstitium.  Myopathic size 
variation, atrophy, myofibre necrosis, fascicular and fascial inflammation and oedema were 
all present in variable combinations.  
 
Fascial Inflammation 
Fascial pathology was observed in 18/30 biopsies. In at least 12 cases, the earliest changes 
were observed on day 1 or day 3, and comprised the accumulation of interstitial oedema 
with neutrophil polymorphs and fibrin largely within the deep fascia and perimysium, with 
very limited or absent myofibre necrosis. By day 7 or day 10, the fascial exudate was much 
more cellular with macrophages dominating. The infiltrate also extended into the fascicles 
from the endomysium with accompanying necrosis and regeneration; generally the fascial 
pathology paralleled the severity of myofibre necrosis by days 7 or 10. In biopsies where the 
muscle-fascia interface was optimally represented, a pathological gradient was clearly 
discernible with more severe fibre damage in the fascicular periphery adjacent to the 
inflamed and oedematous fascia (Figure 1). 
 
Relationships between parameters 
Muscle echogenicity 
RFECHO  values were normally distributed.  In a multivariate regression analysis, presence of 
chronic disease (drawn from the medical notes and hospital and general practice coding for 
management of chronic disease) was associated with RFECHO (r2=0.22, p=0.028, Table 3). 
Patients with chronic disease (n=13) had higher baseline echogenicity than those without 
(n=17) (58.4 (95%CI 49.8-67) vs 44.1 (95%CI 36.1-52.1), p=0.013). 
No relationship was seen between fluid balance and echogenicity (r2=0.00, p0.899, n=30) or 
in the subgroups with and without necrosis (both r2<0.01, p>0.5). 
As a group, RFECHO did not change from admission over 10 days (-3.40 (95%CI -13.5-6.68)%, 
p=0.405). However, ∆RFECHO over 10 days was higher in those who developed muscle 
necrosis than in those who did not (8.2%, (95%CI -5.3- 21.7), n=15 versus -15.0%, (95%CI -
28.9- -1.09), n =15, p=0.016),  whilst baseline echogenicity did not differ between those with 
or without subsequent necrosis (42.66 (95%CI 33.6-51.8) vs. 48.4 (95%CI 41.2-55.6), 
p=0.296). 
 
The AUROC for ∆RFECHO for prediction of myofibre necrosis was 0.74 (95%CI 0.565-0.919, 
p=0.024). The difference between groups was greater when those in whom iatrogenic 
muscle damage could not be ruled out were removed (17.8%, (95CI% 5.0-30.6), n=11 versus 
-15.0%, (95%CI -28.9- -1.09), n=14, p=0.001), with an increased AUROC of 0.85 (95%CI 0.703 
-0.995, p=0.003) as seen in Figures 2 and 3 and the online supplement. 
 
Fascial echogenicity 
Admission FASECHO was associated with admission RFECHO (r2=0.237, p=0.006) but not with 
other potential variables (Table 4).  
In the cohort overall, FASECHO did not change over 10 days (2.0(95%CI -7.32-11.3)% n=30, 
p=0.598). Amongst individuals, change in FASECHO (ΔFASECHO) was correlated with ∆RFECHO 
(r2=0.22 (95%CI 0.116-0.750) p=0.009). The correlation remained significant with the 
exclusion of those patients in whom iatrogenic damage could not be ruled out (r2=0.20 
(95%CI 0.060-0.763), p=0.024 figure 4). 
 
Discussion 
The presence of histologically-confirmed fasciitis (found in the majority of the critically-ill 
patients studied) correlated with that of ultrasound-identified fascial oedema. Oedema, 
neutrophil infiltration and fibrin deposition dominated the early phase of critical illness, with 
macrophage-rich cellular fasciitis extending deeper within the muscle fascicles. 
Accompanying myofibre necrosis and muscle regeneration appeared later.  The presence of 
myofibre necrosis was predicted by increased ultrasound echogenicity during the first week 
of critical illness.  There was no change in the proportion of type 1 and type 2 myofibres 
observed during the first week of critical illness. 
Patho-radiological relationship in the first week of critical illness 
B-mode ultrasound determination of muscle cross-sectional area as an index of muscle 
mass(2, 5, 22, 23), correlates well with both athletic performance in healthy subjects (24, 
25) and with skeletal muscle function in chronic disease (22, 23). Age-related changes in 
muscle quality are associated with reduced function (13, 14), and may be the result of 
infiltration with fat or collagen (26). In addition, qualitative changes have been reported in 
some chronic disease states and have been related to impaired physical function(13, 14, 26).  
B-mode ultrasound was able to detect the development of skeletal muscle necrosis. Such 
muscle necrosis appears anatomically patchy (2, 27-29), which may account for the few 
patients with histologically-diagnosed necrosis who lacked a corresponding change in 
muscle echogenicity: the ultrasound window may not have captured the presence of 
necrotic fibres. 
Critical illness myopathy has been classified by  the presence of  1) non-specific alterations, 
2) selective loss of thick filaments, and, 3) acute necrotisis (30).  The presence of fascial 
pathology in critical illness has, to our knowledge, not been characterised before.  
Histologically-diagnosed fasciitis was present in a majority of our patients and associated 
with increased ultrasound echogenicity, in keeping with similar findings in cases of 
necrotising (18, 19, 31, 32), plantar(33-35), eosinophilic (36, 37) and non-eosinophilic 
fasciitis (38).  Furthermore we clearly identified sequential changes with oedema, neutrophil 
polymorphs and fibrin dominating the early phase (days 1-3), and a macrophage-
predominant cellular fasciitis featuring in the late phase (days 7-10), extending deeper 
within fascicles with accompanying myonecrosis and regeneration.  The association with 
muscle necrosis implies either a common causal link, or an anatomically related “spill-over”; 
as yet no pathophysiological process has been associated with the development of 
myonecrosis. Through its association with pain (39), loss of range of movement and reduced 
flexibility (40), fasciitis could have important associated clinical sequelae and adversely 
effect early mobilisation and rehabilitation, two crucial interventions in preventing and 
treating Intensive care acquired weakness (41). Furthermore, persistence of macrophages in 
skeletal muscle and temporal plasticity in phenotypes (M1 to M2) may adversely affect 
satellite cell function and regeneration, and potentiate fibrosis.  
No change in myofibre proportion was seen between biopsies over the 10 days of study. A 
shift in myofibre phenotype towards an increased proportion of fast- contracting type II 
fibres, and type IIb fibre-specific atrophy is a consequence of disuse, steroid treatment and 
related to a number of clinical conditions including chronic respiratory ambulant disease 
(42). Given the narrow timecourse of the present study, it is not particularly surprising that 
we did not observe any changes in the major fibre types, although we did not distinguish 
between the relative proportions of the two fast fibre subtypes and did not analyse type-
specific fibre atrophy.   That later biopsy may have revealed some evidence of fibre shift 
and/or type-specific atrophy, cannot be excluded. 
An overall positive fluid balance is not unusual in critical illness. However, independently of 
such changes, alterations in factors such as oncotic pressure and microvascular permeability 
may alter fluid distribution between the vascular and tissue compartments. Whilst no 
relationship was seen between fluid balance and change in echogenicity, fluid balance thus 
remains a crude surrogate for fluid state, and does not distinguish between intravascular, 
intracellular and third spaces and fluid shifts between them. 
Study limitations 
Several limitations of the study have been discussed, and sample size remains an issue, 
especially in the context of a radio-pathological validation study. Nevertheless these data 
represent the largest serial muscle biopsy and radiological assessment to date- performing 
larger scale studies may neither be feasible nor ethically appropriate.  Comparing biopsies of 
Vastus Lateralis with ultrasound measurements of Rectus Femoris may lead to potential 
bias. This is an unavoidable methodological issue in unstable ventilated patients, as Vastus 
Lateralis cross sectional area measurements requires patient repositioning (best avoided on 
non-clinical grounds), and Rectus Femoris is anatomically related to large vascular structures 
(making biopsy hazardous). . Whilst these muscles are structurally and functionally different 
components of Quadriceps Femoris, previous reports have validated RFCSA as a measure of 
change in muscle mass (2). Had ultrasound and biopsies been performed on the same 
muscle, the predicative capacity of ultrasound may have been greatly enhanced. A benefit 
of this method is that iatrogenic contamination of the ultrasound measurements is unlikely 
to be an issue. 
 
Future studies might broaden subject recruitment, and extend the period of study beyond 
the first ten days providing greater insight into muscle wasting and changes in architecture 
during the recovery phase of critical illness.  The lack of premorbid functional data limits our 
ability to infer the effect of changes in muscle echogenicity (and therefore muscle necrosis) 
may have on functional impairment. 
 
Clinical implications 
Whilst what constitutes a ‘clinically significant’ change in muscle echogenicity remains 
unknown, muscle echo intensity is negatively correlated with muscle strength (12, 14, 43) 
and performance (13), independent of muscle mass. The association between change in 
muscle echogenicity and the presence of muscle necrosis may explain the significant 
variation in change in muscle echogenicity seen in published ultrasound data (without 
contemporaneous histological examination) in critically ill patients (17).  
Inflammation of skeletal muscle fascia is common amongst the critically ill, and precedes the 
development of myonecrosis. Both can be detected by ultrasound- a simple, inexpensive 
and widely available tool that may facilitate the investigation of the relationship between 
muscle necrosis and fasciitis, impaired functional outcome, and the genesis of the 
generalised body pain so common in critical care survivors (1).  Detailed characterisation of 
the immune inflammatory response may shed light on the yet poorly understood 
mechanisms that could causally link fascial and muscle inflammation in during acute critical 
illness. Future outcome studies, and those focused on rehabilitation, may be able to use 
admission muscle mass and muscle quality to identify those likely to respond less well to 
resistance training and rehabilitation (43). 
Future research should focus on both the aetiology of muscle necrosis, and its effect on 
functional capacity in both the acute phase and on long term disability. The presence of 
muscle necrosis may be responsible for failure to respond to early rehabilitation (44). Single 
skeletal muscle fibre assessments of muscle contraction (45), the interplay between 
myonecrosis, systemic inflammation (46) and regeneration (47) need to be examined. 
Comparative work with other non-invasive methods of assessment of muscle bulk and 
quality should be performed (48). Importantly, muscle echogenicity may be able to assess 
novel interventions (49) for potential muscle damage (50). 
 
Conclusions 
Myofibre necrosis and fascial inflammation in critically ill patients can be detected 
noninvasively using B-mode ultrasound. Fasciitis precedes and frequently accompanies 
muscle necrosis, and is dominated by macrophages in the sub-acute phase. The effect of 
these qualitative changes in skeletal muscle on early mobilisation, rehabilitation and 
subsequent functional debility warrant further investigation, in tandem with the 
pathophysiology underlying fascial and muscle inflammation and necrosis.  
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 Figure Legends: 
Figure 1: Fascial and Myofibre pathology in skeletal muscle biopsies from critically ill 
patients.A, B: Sections from a control muscle biopsy showing histologically normal 
appearances. The deep fascia condenses on the surface of the fascicles forming the 
epimysium (Star, A). Perimysial connective tissue septa branch off from the epimysium 
dividing the muscle in to smaller fascicles (Star, B). The endomysium comprises the 
extracellular matrix surrounding individual myofibres. C: Section from patient taken on day 
1 shows pre-existing myopathic changes comprising mild variation in fibre size and 
increased internal nuclei. D: Day 3 biopsy taken showing prominent oedema with a few 
neutrophil polymorphs and some fibrin in the epimysium. The adjacent fascicle is largely 
unaffected. E, F: Day 10 biopsy from the same patient shows a cellular inflammatory 
infiltrate in the fascia extending deep in to the adjacent fascicles with accompanying 
myonecrosis and regeneration. High magnification image from the same region (F) shows 
the inflammatory cells to be predominantly macrophages. G: Day 3 biopsy showing mild 
oedema and a few inflammatory cells in the perimysium (Star). The adjacent fascicles show 
rare necrotic fibres, but appear largely intact. H: Day 10 biopsy from the same patient  (G) 
that shows a more florid, cellular, macrophage-predominant destructive fasciitis with 
myonecrosis. I: Day 7 biopsy showing epimysial oedema and inflammation. A 3-4 cell thick 
sliver of the adjacent fascicular periphery shows marked pathology with myonecrosis and 
regeneration (inset) and a decreasing gradient of abnormality towards the fascicular centre. 
All biopsies were taken from the vastus lateralis and pathology was assessed on frozen 
sections stained with haematoxylin and eosin.  
 
Figure 2: Percentage change in Rectus Femoris echogenicity (%∆RFECHO) over 10 days for 
those patients that developed myofibre necrosis and those that did not. Those patients in 
who Iatrogenic necrosis could not be ruled out are marked with a clear box 
 
Figure 3: Representative paired ultrasound and haematoxylin and eosin stained sections of a 
patient on day 1 and day 10, demonstrating the reduction in Rectus Femoris Cross Sectional 
Area, an increase in Rectus Femoris echogenicity and the presence of myofibre necrosis with 
cellular infiltrate on day 10. Abbreviations: F=Fascial layer, RF=Rectus Femoris, VI=Vastus 
Intermedius and B=Femoral Bone 
 
Figure 4: Relationship between muscle and fascial echogenicity over 10 days, n=30. Those 
patients in who Iatrogenic necrosis could not be ruled out are marked with as open circles. 
%ΔFASECHO = Percentage change in fascial echogenicity in 10 days.  %∆RFECHO =Percentage 
change in Rectus Femoris echogenicity over 10 days 
 
 
